248 related articles for article (PubMed ID: 24202323)
1. Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia.
Vajen B; Thomay K; Schlegelberger B
Cancers (Basel); 2013 Jul; 5(3):857-74. PubMed ID: 24202323
[TBL] [Abstract][Full Text] [Related]
2. Mutations of myelodysplastic syndromes (MDS): An update.
Ganguly BB; Kadam NN
Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
[TBL] [Abstract][Full Text] [Related]
3. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
[TBL] [Abstract][Full Text] [Related]
4. [Epigenetic dysregulation in myelodysplastic syndromes].
Sashida G
Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
[TBL] [Abstract][Full Text] [Related]
5. Genetics of myelodysplastic syndromes: new insights.
Graubert T; Walter MJ
Hematology Am Soc Hematol Educ Program; 2011; 2011():543-9. PubMed ID: 22160087
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
Eriksson A; Lennartsson A; Lehmann S
Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
[TBL] [Abstract][Full Text] [Related]
7. Genetic abnormalities and pathophysiology of MDS.
Hosono N
Int J Clin Oncol; 2019 Aug; 24(8):885-892. PubMed ID: 31093808
[TBL] [Abstract][Full Text] [Related]
8. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
9. Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.
Castelli G; Pelosi E; Testa U
Onco Targets Ther; 2018; 11():131-155. PubMed ID: 29343972
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.
de Souza Fernandez T; Ornellas MH; Otero de Carvalho L; Tabak D; Abdelhay E
Leuk Res; 2000 Oct; 24(10):839-48. PubMed ID: 10996202
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening and chromosomal instability in myelodysplastic syndromes.
Lange K; Holm L; Vang Nielsen K; Hahn A; Hofmann W; Kreipe H; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2010 Mar; 49(3):260-9. PubMed ID: 19998444
[TBL] [Abstract][Full Text] [Related]
13. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS.
Fern L; Pallis M; Ian Carter G; Seedhouse C; Russell N; Byrne J
Br J Haematol; 2004 Jul; 126(1):63-71. PubMed ID: 15198733
[TBL] [Abstract][Full Text] [Related]
14. Update on cytogenetic and molecular changes in myelodysplastic syndromes.
Schlegelberger B; Göhring G; Thol F; Heuser M
Leuk Lymphoma; 2012 Apr; 53(4):525-36. PubMed ID: 21877899
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal Instability in Acute Myeloid Leukemia.
de Oliveira Lisboa M; Brofman PRS; Schmid-Braz AT; Rangel-Pozzo A; Mai S
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071283
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Expression of
de Souza Fernandez T; Fonseca Alvarenga T; Almeida Antônio de Kós E; Lamim Lovatel V; Tavares RC; da Costa ES; de Souza Fernandez C; Abdelhay E
Biomed Res Int; 2019; 2019():3176565. PubMed ID: 31886200
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group.
Heilig CE; Löffler H; Mahlknecht U; Janssen JW; Ho AD; Jauch A; Krämer A
J Cell Mol Med; 2010 Apr; 14(4):895-902. PubMed ID: 19754665
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase in normal and leukemic hematopoietic cells.
Engelhardt M; Wäsch R; Guo Y
Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation as a pathogenic event and as a therapeutic target in AML.
Schoofs T; Müller-Tidow C
Cancer Treat Rev; 2011; 37 Suppl 1():S13-8. PubMed ID: 21612874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
